PMC Articles for MedGen (Select 272113) - PMC

Links from MedGen

Items: 1 to 20 of 129

<< First< Prev

Page of 7

Select item 106705101.

Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma

Hayley Higgins, Abanoub Nakhla, Andrew Lotfalla, David Khalil, Parth Doshi, Vandan Thakkar, Dorsa Shirini, Maria Bebawy, Samy Ammari, Egesta Lopci, Lawrence H. Schwartz, Michael Postow, Laurent Dercle

Diagnostics (Basel) 2023 Nov; 13(22): 3483. Published online 2023 Nov 20. doi: 10.3390/diagnostics13223483

PMCID:: PMC10670510

Article PDF–2.0M

Select item 105579632.

Development and validation of two online dynamic nomograms for patients with non‐distant metastatic cutaneous melanoma based on surgical approaches

Shiqi Wang, Yuedong Chen, Jiawei Sun, Ran Mo, Qian Tan

Cancer Med. 2023 Sep; 12(18): 18479–18490. Published online 2023 Aug 18. doi: 10.1002/cam4.6448

PMCID:: PMC10557963

Article PDF–1.1M

Select item 102549873.

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study

Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo A Ascierto, Paul C Lorigan, Cornelia Mauch, Marlana Orloff, Thomas R Jeffry Evans, Chris Holland, Ramakrishna Edukulla, Shaad E Abedin, Mark R Middleton

J Immunother Cancer. 2023; 11(6): e006747. Published online 2023 Jun 7. doi: 10.1136/jitc-2023-006747

PMCID:: PMC10254987

Article PDF–1.2M

Select item 101661614.

Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission

Kaviyon Sadrolashrafi, Wolfram Samlowski

Oncologist. 2023 May; 28(5): e270–e275. Published online 2023 Feb 28. doi: 10.1093/oncolo/oyad016

PMCID:: PMC10166161

Article PDF–175K

Select item 97500925.

VOGT–KOYANAGI–HARADA-LIKE UVEITIS FOLLOWED BY MELANOMA-ASSOCIATED RETINOPATHY WITH FOCAL CHORIORETINAL ATROPHY AND CHOROIDAL NEOVASCULARIZATION IN A PATIENT WITH METASTATIC CUTANEOUS MELANOMA

Caleb C. Ng, Joseph B. Alsberge, Ying Qian, K. Bailey Freund, Emmett T. Cunningham, Jr

Retin Cases Brief Rep. 2023 Jan; 17(1): 18–22. Published online 2020 Dec 21. doi: 10.1097/ICB.0000000000001113

PMCID:: PMC9750092

Article PDF–441K

Select item 92657796.

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma

Dirk Tomsitz, Max Schlaak, Sarah Zierold, Giulia Pesch, Thomas U. Schulz, Genoveva Müller, Christine Zecha, Lars E. French, Lucie Heinzerling

Cancers (Basel) 2022 Jul; 14(13): 3282. Published online 2022 Jul 5. doi: 10.3390/cancers14133282

PMCID:: PMC9265779

Article PDF–620K

Select item 86158367.

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma

Paula Colón-Bolea, Rocío García-Gómez, Berta Casar

Biomolecules. 2021 Nov; 11(11): 1554. Published online 2021 Oct 20. doi: 10.3390/biom11111554

PMCID:: PMC8615836

Article PDF–5.1M

Select item 84028258.

Metastatic Cutaneous Melanoma in a White African Lioness (Panthera leo)

Louise van der Weyden, Peter Caldwell, Liesl van Rooyen, Emily P. Mitchell, Nicolize O’Dell

Vet Sci. 2021 Aug; 8(8): 154. Published online 2021 Aug 1. doi: 10.3390/vetsci8080154

PMCID:: PMC8402825

Article PDF–4.5M

Select item 83694779.

Interference of COVID-19 Vaccination With PET/CT Leads to Unnecessary Additional Imaging in a Patient With Metastatic Cutaneous Melanoma—Case Report

Rafał Czepczyński, Jolanta Szczurek, Jacek Mackiewicz, Marek Ruchała

Front Oncol. 2021; 11: 690443. Published online 2021 Aug 3. doi: 10.3389/fonc.2021.690443

PMCID:: PMC8369477

Article PDF–6.1M

Select item 827424310.

Plasma proteome alterations by MAPK inhibitors in BRAF^V600-mutated metastatic cutaneous melanoma

Haris Babačić, Hanna Eriksson, Maria Pernemalm

Neoplasia. 2021 Aug; 23(8): 783–791. Published online 2021 Jul 8. doi: 10.1016/j.neo.2021.06.002

PMCID:: PMC8274243

Article PDF–1.0M

Select item 802536911.

Targeting the IL-2 Inducible Kinase in Melanoma; A Phase 2 Study of Ibrutinib in Systemic Treatment-Refractory Distant Metastatic Cutaneous Melanoma: Preclinical Rationale, Biology, and Clinical Activity (NCI9922)

Stergios J. Moschos, Zeynep Eroglu, Nikhil I. Khushalani, Kari L. Kendra, George Ansstas, Gino K. In, Peng Wang, Glenn Liu, Frances A. Collichio, Paul B. Googe, Craig C. Carson, Karen McKinnon, Hsing-Hui Wang, Nana Nikolaishvilli-Feinberg, Anastasia Ivanova, Christy C. Arrowood, Nancy Garrett-Mead, Kathleen C. Conway, Sharon N. Edmiston, David W. Ollila, Jonathan S. Serody, Nancy E. Thomas, S. Percy Ivy, Lokesh Agrawal, Elizabeth C. Dees, James L. Abbruzzese

Melanoma Res. Author manuscript; available in PMC 2022 Apr 1.

Published in final edited form as: Melanoma Res. 2021 Apr 1; 31(2): 162–172. doi: 10.1097/CMR.0000000000000726

PMCID:: PMC8025369

Article PDF–1.4M

Select item 794438512.

Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors

Jessica J. Waninger, Vincent T. Ma, Sara Journey, Jeremy Skvarce, Zoey Chopra, Alangoya Tezel, Alex K. Bryant, Charles Mayo, Yilun Sun, Kamya Sankar, Nithya Ramnath, Christopher Lao, Jeremy B. Sussman, Leslie Fecher, Ajjai Alva, Michael D. Green

JAMA Netw Open. 2021 Mar; 4(3): e210980. Published online 2021 Mar 9. doi: 10.1001/jamanetworkopen.2021.0980

PMCID:: PMC7944385

Article

Select item 765994613.

In Cellulo Evaluation of the Therapeutic Potential of NHC Platinum Compounds in Metastatic Cutaneous Melanoma

Elsa Charignon, Mathilde Bouché, Caroline Clave-Darcissac, Georges Dahm, Gabriel Ichim, Anthony Clotagatide, Hichem C. Mertani, Philippe Telouk, Julie Caramel, Jean-Jacques Diaz, Stéphane Bellemin-Laponnaz, Philippe Bouvet, Claire Billotey

Int J Mol Sci. 2020 Nov; 21(21): 7826. Published online 2020 Oct 22. doi: 10.3390/ijms21217826

PMCID:: PMC7659946

Article PDF–1016K

Select item 747117514.

Improved Perioperative Seroma and Complication Rates Following the Application of a 2-Layer Negative Pressure Wound Therapy System After Inguinal Lymphadenectomy for Metastatic Cutaneous Melanoma

Marc D. Moncrieff, Riti A. Sharma, Esther Gathura, Martin J. Heaton

Ann Surg Oncol. 2020; 27(10): 3692–3701. Published online 2020 Jun 5. doi: 10.1245/s10434-020-08513-7

PMCID:: PMC7471175

Article PDF–827K

Select item 725300715.

In-depth plasma proteomics reveals increase in circulating PD-1 during anti-PD-1 immunotherapy in patients with metastatic cutaneous melanoma

Haris Babačić, Janne Lehtiö, Yago Pico de Coaña, Maria Pernemalm, Hanna Eriksson

J Immunother Cancer. 2020; 8(1): e000204. Published online 2020 May 20. doi: 10.1136/jitc-2019-000204

PMCID:: PMC7253007

Article PDF–5.9M

Select item 722594316.

Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs

Brenda Leeneman, Carin A. Uyl-de Groot, Maureen J. B. Aarts, Alexander C. J. van Akkooi, Franchette W. P. J. van den Berkmortel, Alfons J. M. van den Eertwegh, Jan Willem B. de Groot, Karin H. Herbschleb, Jacobus J. M. van der Hoeven, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Karijn P. M. Suijkerbuijk, Albert J. ten Tije, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, John B. A. G. Haanen, Margreet G. Franken

Cancers (Basel) 2020 Apr; 12(4): 1003. Published online 2020 Apr 18. doi: 10.3390/cancers12041003